Related Experiment Video
Updated: Oct 25, 2025

08:58
Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
10.7K
Protein detection in blood with single-molecule imaging
Chih-Ping Mao1,2, Shih-Chin Wang3, Yu-Pin Su4
1Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Science Advances
|August 12, 2021
Summary
Single-molecule augmented capture (SMAC) enables ultrasensitive protein detection in blood, improving early disease diagnosis. This breakthrough imaging technique achieves subfemtomolar sensitivity for biomarker analysis.
Area of Science:
- Biotechnology
- Medical Diagnostics
- Molecular Imaging
Background:
- Early disease diagnosis relies on detecting biomarker proteins in patient blood.
- Current single-molecule imaging methods lack the sensitivity for clinical applications, limited to picomolar concentrations.
- Subfemtomolar detection is needed to analyze low-abundance biomarkers in various diseases.
Purpose of the Study:
- To introduce a novel single-molecule imaging technique, SMAC, for ultrasensitive protein quantification.
- To demonstrate the capability of SMAC to detect protein biomarkers at subfemtomolar concentrations.
- To validate SMAC's utility in analyzing diverse protein types in human blood samples for disease profiling.
Main Methods:
- Development of single-molecule augmented capture (SMAC) technique.
- Application of SMAC for imaging and quantifying individual protein molecules.
- Testing SMAC with human blood samples to analyze secreted, membrane, and intracellular proteins.
Main Results:
- SMAC achieves detection limits in the subfemtomolar (<10-15 M) range.
- Successfully quantified individual protein molecules, including disease-associated proteins, membrane proteins, and rare intracellular proteins.
- Demonstrated SMAC's effectiveness across various applications using human blood samples.
Conclusions:
- SMAC significantly advances single-molecule imaging sensitivity, surpassing picomolar limitations.
- This technique enables the detection of low-abundance protein biomarkers crucial for early disease diagnosis.
- SMAC holds potential for noninvasive disease profiling and clinical translation of single-molecule imaging.

